BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Osiris Therapeutics, Inc. 

7015 Albert Einstein Drive

Columbia  Maryland  21231-3043  U.S.A.
Phone: 443-545-1800 Fax: 443-545-1701


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Osiris Therapeutics, Inc. (OSIR) And Arthrex, Inc. Announce An Exclusive Partnership For The Commercialization And Development Of Cartiform® 10/17/2014 7:49:50 AM
Osiris Therapeutics, Inc. (OSIR) To Present Three Studies On Benefits Of Cryopreserved Placental Membranes For Chronic Wounds 10/16/2014 8:15:19 AM
Osiris Therapeutics, Inc. (OSIR) Announces Third Quarter 2014 Financial Results Conference Call 10/13/2014 8:25:34 AM
Osiris Therapeutics, Inc. (OSIR) To Present At The 2014 Stem Cell Meeting On The Mesa 9/25/2014 9:45:10 AM
Osiris Therapeutics, Inc. (OSIR) Release: Grafix® Featured In Plenary Session Oral Presentation At The Joint Annual Meeting Of The Eastern And New England Vascular Societies 9/16/2014 10:28:09 AM
Osiris Therapeutics, Inc. (OSIR) Release: Grafix® Featured In Plenary Session Oral Presentation At The Joint Annual Meeting Of The Eastern And New England Vascular Societies 9/16/2014 9:05:07 AM
Osiris Therapeutics, Inc. (OSIR) Release: Grafix® Randomized Controlled Clinical Trial Recognized As High Quality DFU Trial In Recent Wounds Supplement 9/11/2014 8:03:05 AM
Osiris Therapeutics, Inc. (OSIR) Announces Second Quarter 2014 Financial Results: Revenue Up 32% Over Previous Quarter 8/7/2014 10:59:27 AM
Grafix® Manuscript From Osiris Therapeutics, Inc. (OSIR)’ Multi-center, Randomized, Controlled Clinical Trial Available Electronically In Peer-Reviewed Journal 7/23/2014 12:21:34 PM
Osiris Therapeutics, Inc. (OSIR) Expands Its Grafix® Product Portfolio And Launches Additional Sizes 7/17/2014 11:10:20 AM
12345678910...